Phase II trial of ADXS11-001 vaccine for HPV-related oropharyngeal cancer

Project: Research project

Project Details

Description

Phase II trial of ADXS11-001 vaccine for HPV-related oropharyngeal cancer Phase II trial of ADXS11-001 vaccine for HPV-related oropharyngeal cancer
StatusFinished
Effective start/end date9/10/15 → 7/31/16

Funding

  • HHS: Food and Drug Administration (FDA): $9,270.00
View all
View less

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint